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ABSTRACT
Hyalinizing clear cell carcinoma presents as a painless submucosal mass commonly located at the palate and base of 
tongue. It is a rare tumour and has often been misdiagnosed for other more common tumours with clear cytoplasm, 
such as acinic cell carcinoma, clear cell oncocytoma or mucoepidermoid carcinoma. HCCC has been reported as a 
low grade malignant tumour with a high rate of cervical metastases. Due to its rarity, there is no treatment protocol. 
However, the treatment of choice is wide local excision and the neck disease is treated with neck dissection or ra-
diotherapy or both with no conclusive outcome as incidence is too low or underreported with no long term follow 
up. Our case highlights the diagnosis difficulties in such rare cases, and the need for longer follow up post excision 
to determine outcome and recurrence rates. 
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INTRODUCTION
Hyalinizing clear cell carcinoma (HCCC) is a rare, 
malignant tumour accounting for less than 10% of 
head and neck cancers. It commonly affects the minor 
salivary glands, particularly in women. We report a case 
of clear cell carcinoma of the soft palate which was 
successfully treated with wide local excision and has 
remained asymptomatic after a 5-year follow up. Due 
to the rarity of this tumour, there is a lack of evidence 
for the best treatment protocol in the reported literature. 
CASE REPORT
A 45 –year- old gentleman presented to our department 
with  painless mass in the soft palate for 3 months. He 
experienced some bleeding from the mass after meals. 
He has no history of trauma. No constitutional symptoms. 
He is a non smoker. On examination, there was a 2x2cm 
soft, smooth, blueish swelling over left soft palate, 
which bleeds on contact as shown in fig.1. The lesion 
was confined to soft palate and not communicating with 
nasopharynx .There was no loosening of teeth. There 
was no palpable neck nodes. CT showed a well defined 
focal lesion at the left side the soft palate, measuring 
1.3cm x 1.5cm x 1.5cm. The lesion is heterogenous and 
mildly enhancing, with no internal calcification and 
no surrounding bony erosions. There is no significant 
vascularity surrounding the lesion. He underwent a wide 
local excision under general anaesthesia. There was no 
biopsy taken preoperatively, as the wide local excision 
was meant to be diagnostic as well as therapeutic. 
Intraoperatively, the mass is located at the junction 
between the hard and the soft palate, involving the 
Figure 1: Intraoral photograph of the patient, showing 2x2cm 
well defined focal lesion at the left side of the soft palate, at 
the junction of the hard and soft palate
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palatoglossus muscle. Histopathological examination 
showed a vaguely circumscribed tumour, partly covered 
by squamous epithelium and skeletal muscle fibres 
within the deeper resected areas. Tumour cells arising 
from minor salivary glandular tissue are composed of 
solid sheets, trabeculae cords of large, monomorphic 
clear cells infiltrating the surrounding skeletal muscles 
fibres and perineurium, however there was clear 
margins exceeding 5 millimetres. Numerous bands of 
intervening hyalinized stroma are seen and there was 
glycogen within the tumour cells. Immunohistochemical 
staining are positive for cytokeratin (CK5,6, and 7) and 
P63, but negative for S100, SMA, and CEA. Patient did 
not undergo radiotherapy as margins were clear, and 
there was no recurrence on one year follow up. 
DISCUSSION
Hyalinizing clear cell carcinoma (HCCC) most 
commonly occurs in minor salivary glands of the oral 
cavity of middle aged women, affecting mainly the 
palate and base of tongue (1). Other sites include, 
the parotid gland, subglottic larynx, nasopharynx and 
hypopharynx, which are less common.(2)
Global annual incidence of all salivary gland tumours 
are 0.4-13.5 cases per 100,000 population. In the U.S., 
salivary gland tumour accounts for 6% of all head and 
neck cancers and 0.3% of all malignancies.(3) There 
is a higher frequency of salivary gland tumours in 
Malays rather than Chinese and Indians. (3)  50% of the 
malignant tumours of the salivary gland arise from the 
minor salivary glands. (3)
Clinical presentation is a slow growing painless, 
submucosal mass in the oral cavity without surface 
ulceration unless subjected to secondary trauma. Other 
presentations are bleeding from the mass, pain at the 
mass when swallowing or from ill-fitting dentures. 
Patients present with a foreign body sensation in the 
throat for lesions at the base of tongue. Milchgrub et 
al reported 2 out of 11 patients that had cervical node 
metastases on neck dissection.(1)
HCCC is usually infiltrative and can spread to 
locoregional lymph nodes. Perineural spead is often 
seen(1). An important feature of this tumour is, its slow 
growing nature, hence it can be characterized as a low 
grade malignant tumour. 
Histologically, it is characterized by a monomorphous 
population of polygonal to rounds cells that have 
clear cytoplasm with standard haematoxylin and eosin 
stains. Tumour cells are arranged in solid cell masses, 
sheets, nests, cords or trabeculae with absence of ductal 
structures and prominent glycogen content.(1,3) Stroma 
is composed of thick bands of hyalinized collagen. 
Due to its rarity, it can be easily misdiagnosed for other 
tumours that have clear cytoplasm such as acinic cell 
carcinoma, clear cell oncocytoma, mucoepidermoid 
carcinoma, epithelial-myoepithelial carcinoma, 
sebaceous carcinoma, metastatic renal cell carcinoma, 
polymorphous low grade adenocarcinoma, pleomorphic 
adenoma and Pindborg tumour (1,3,4).
Immunohistochemical staining aids in diagnosis by 
helping to identify the cell of origin of the tumour. 
Stains are positive for PAS but negative for mucin. The 
cells are reactive with antibodies against cytokeratins 
and epithelial membrane antigen but are non reactive 
for S-100 protein antigen and smooth muscle actin. 
Diagnosis is made by exclusion once other specific 
tumours with clear cell morphology has been excluded.
(4).  Myoepithelial cells show immunoreactivity to 
S-100 protein and vimentin. Epithelial-myoepithelial 
carcinoma are positive for S-100 protein, muscle 
specific actin. 
HCCC is rare, with no clear treatment protocol. 
However, staging follows TNM Classification of oral 
cavity American Joint Committee on Cancer (AJCC) 8th 
Edition. Although the tumour is reported as a low grade 
malignancy, there has been reports of metastases to 
neck and lung. Since hyalinizing clear cell carcinoma 
is a tumour with low malignant potential, wide local 
excision is the treatment of choice. However, results 
from a 25-year review by Solar AA et al, highlighted 
the importance of a thorough cervical lymph nodes 
assessment, as they found a high rate of cervical lymph 
node metastasis. For this reason, neck dissection should 
be considered in the management of HCCC. Pre- or post-
operative radiotherapy has been reported, with some 
known recurrence despite undergoing post-operative 
radiotherapy (5). In our patient, radiotherapy was not 
given as the margins were clear. 
Solar AA et al reported a series of 8 patients, where 
there was recurrence in 3 of 8 patients, one of which 
had undergone post op radiotherapy (2). This may be 
unrepresentative, as it is a low incidence or could be 
Figure 2: Clear cells (black arrow) with bands of intervening 
hyalinized stroma (blue arrow)
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underreported with short follow up.  Table I shows a 
summary of the reported cases throughout the years, 
outlining presenting complaint, along with treatment 
and outcome. 
There is no trend emerging as such, when we compared 
the previous publications, authors found that the 
incidence is very low.even the age group varies from 25 
to 86, with a median of 57.  There is difference in gender 
predilection as well, 71% of HCCC occur in females, 
from the literature (2). After extensive literature review 
and with the limited available data pertaining to our 
case report, our proposed protocol is in Table II.
CONCLUSION
The purpose of this case report is to add the presentation 
and long term outcome of this rare entity to the 
literature. Awareness of this rare pathology will reduce 
the misdiagnosis from other clear cell tumours. 
Table I: A summary of the reported cases throughout the years, outlining presenting complaint, along with treatment and outcome
REFERENCE NO. 
OF PA-
TIENTS
AGE 
(years)
SEX 
(Male/
Female)
CLINICAL 
COM-
PLAINT
DURA-
TION
(months)
LOCATION SIZE 
(cm) 
STAGE TREAMENT Adjuvant: 
Radiotherapy/ 
Chemotherapy
METAS-
TASIS
FOL-
LOW UP 
(months)
OUTCOME
Grenevicki, 
20018
1 53 F Epistaxis
Painless 
palatal 
mass
2 weeks
9 months 
Hard Palate 5 Stage IV Chemother-
apy
Refused radio-
therapy. 
Yes 
(Lungs)
36 Poor 
Manoharan, 
20029
1 40 F Painless 
swelling, 
left floor of 
mouth
24 Left side 
of mouth 
to floor of 
mouth with 
Left sub-
mandibular 
lymph node 
5 Stage IV Left hemi- 
mandib-
ulectomy, 
inferior al-
veolar nerve 
resection 
Selective 
neck dissec-
tion
- Nil 22 No recurrence
Chao, 
200410
1 42 Female Painless, 
palatal 
mass
36 Hard palate 2 Stage 1 Wide 
excision 
of tumour, 
excision of 
underlying 
palatal bone 
and maxilla 
- Nil 8 No recurrence 
Solar, 
20083
8 34-85 M:F
2:6
Painless, 
non ulcer-
ated mass 
(6 patients) 
Ulcerated 
painful 
mass (2 
patients) 
- Hard Palate 
(3) 
Maxilla (2) 
FOM (1) 
Buccal (1) 
Maxillary 
vestibule (1)
1-3 Stage I 
(3 pa-
tients) 
Stage II 
(2 pa-
tients) 
Rest (un-
known) 
Wide exci-
sion (all) 
Radiothera-
py (3) 
Chemothera-
py (1)
Nil >12 
years
3 recurrent 
disease: 
Stage 1(2) 
Stage 2 (2) 
O’Sulli-
van-Meija, 
200911
8 25-86 M:F
2:6
Painless 
intraoral 
mass/ulcer-
ation 
- Stage I 
(4 pa-
tients)
Stage II 
(2 pa-
tients)
Stage 
III (1 
patient)
1 is un-
known
Wide 
excision 
1 had adjuvant 
radiotherapy 
Nil 1-10 
years
Stage I (1 recur-
rence)
Stage II (1 
recurrence)
Stage III (no 
recurrence)
Agrawal, 
201412
1 52 F Painless 
mass 
12 Hard Palate 2.5 Stage II Hemi-max-
illectomy, 
RND 
Nil (margins 
clear) 
Nil 12 No recurrence 
Jayasree, 
201613
1 40 F Painless 
intraoral 
mass, 
right facial 
swelling
7 years Hard Palate 7 Stage IV Wide resec-
tion
Defaulted 
radiotherapy
- - -
This case
Safuraa, 
2018
1 45 M Painless, 
palatal 
mass
3 Hard palate 1.5 Stage I Wide 
excision 
- 12 No recurrence 
  
Table III: Management guidelines 
Stage Management
I Wide excision 
II Wide excision 
III Wide excision and neck dissection
IV A, IV B Wide excision and neck dissection
IV C Chemotherapy
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